跳至主要内容
临床试验/NCT04714658
NCT04714658尚未招募不适用

Efficiency of a Therapeutic Patient Education Program in Myasthenia Gravis

University Hospital, Strasbourg, France0 个研究点目标入组 100 人开始时间: 2021年1月22日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
主要终点
Brief Illness Perception Questionnaire

研究概览

简要总结

Patient therapeutic education (PTE) has become "a must" in the modern management of chronic diseases. Its main objective is to improve compliance with treatment and the application of preventive measures. The main goal of this study is to assess the influence of the therapeutic education program on the perception of the disease in patients with autoimmune myasthenia. Secondary objectives are to assess quality of life, patient satisfaction of the PTE program, the acquisition of therapeutic goals and the influence of therapeutic education on the evolution of autoimmune myasthenia Study team hypothesize that therapeutic education could improve the patient's perception of myasthenia and its quality of life. By improving patient's adherence to treatments and his knowledge of the disease, it could also improve the evolution of myasthenia gravis. Study team suppose that PTE program can reduce the absenteeism at work, the number and duration of hospitalizations, particularly those in intensive care units.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with generalized autoimmune myasthenia with Acetylcholine Receptor Antibodies (AChR Ab) or with antibodies to the muscle-specific receptor tyrosine kinase (MuSK Ab)
  • Patient agreeing to participate in the therapeutic education program
  • Signing consent
  • Subject affiliated with a health insurance social protection regiment

排除标准

  • Patients without serological confirmation of myasthenia or pure ocular form
  • Patient with cognitive impairment or behavioral problems that, in the investigator's opinion, will compromise their ability to comply with study procedures
  • Refusal of the patient to participate in the study
  • Patient who has already benefited from the therapeutic education program in myasthenia
  • Age < 18 y.o.
  • Subject under safeguarding justice
  • Subject under guardianship or under curatorship

结局指标

主要结局

Brief Illness Perception Questionnaire

时间窗: 6 month after the first visit

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

相似试验